Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
January 4, 2022
Tags:
Dr. Ashish Patel, of The NIHR Guy’s and St Thomas’ BRC, discusses his work on a new engineered monocyte therapy for the treatment of fibrotic interstitial lung disease in patients who have recovered from COVID-19.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
